Gender disparities in time-to-initiation of cardioprotective glucose-lowering drugs in patients with type 2 diabetes and cardiovascular disease: a Danish nationwide cohort study

BACKGROUND: We aimed to examine the impact of gender and specific type of cardiovascular disease (CVD) diagnosis (ischemic heart disease [IHD], heart failure, peripheral artery disease [PAD] or stroke) on time-to-initiation of either a sodium glucose cotransporter 2 inhibitor or glucagon-like peptid...

Descripción completa

Detalles Bibliográficos
Autores principales: Funck, Kristian Løkke, Bjerg, Lasse, Isaksen, Anders Aasted, Sandbæk, Annelli, Grove, Erik Lerkevang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737743/
https://www.ncbi.nlm.nih.gov/pubmed/36496402
http://dx.doi.org/10.1186/s12933-022-01713-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737743/
https://www.ncbi.nlm.nih.gov/pubmed/36496402
http://dx.doi.org/10.1186/s12933-022-01713-3

Ejemplares similares